Literature DB >> 2790703

Massive pulmonary hemangiopericytoma. An innovative approach to evaluation and treatment.

V W Rusch1, W P Shuman, R Schmidt, G E Laramore.   

Abstract

The authors report the case of a 39-year-old woman with a massive malignant pulmonary hemangiopericytoma. The clinical presentation and histologic findings were typical of this rare entity, but workup and treatment were challenging because of the size and location of the tumor. Magnetic resonance imaging (MRI) proved to be critical in the preoperative evaluation because of its unique ability to delineate the precise anatomical extent of this highly vascular neoplasm. Previous treatment of this patient with exploratory thoracotomy and chemotherapy had been unsuccessful. The authors used an innovative approach to treatment which included complete surgical resection via combined median sternotomy and thoracotomy, along with intraoperative and postoperative radiotherapy. The patient is disease-free 28 months after surgery.

Entities:  

Mesh:

Year:  1989        PMID: 2790703     DOI: 10.1002/1097-0142(19891101)64:9<1928::aid-cncr2820640928>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Magnetic resonance imaging of cardiac hemangiopericytoma.

Authors:  Y Sato; K Togawa; K Ogawa; M Hashimoto; T Sakamaki; K Kanmatsuse
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

Review 2.  Resection of primary pulmonary hemangiopericytoma: a report of two cases.

Authors:  M Kuroya; H Yokomise; K Inui; O Ike; H Mizuno; H Wada; S Hitomi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Primary Hemangiopericytoma Arising in Extralobar Pulmonary Sequestration: A Coincidence or Two Rare Disorders?

Authors:  Christos F Kampolis; Christos Damaskos; Angeliki A Loukeri; Nikolaos Garmpis; Anna Garmpi; Ioannis Tomos; Eleftherios Spartalis; Dimitrios Dimitroulis; Alexandros Patsouras; Marousa Douskou; Spyros A Papiris; Periklis Tomos
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

4.  Primary mediastinal hemangiopericytoma.

Authors:  A Chnaris; N Barbetakis; A Efstathiou; I Fessatidis
Journal:  World J Surg Oncol       Date:  2006-04-27       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.